dosing when switching from semaglutide to tirzepatide transitioning transitioning from semaglutide to tirzepatide Tirzepatide (MOUNJARO®/ZEPBOUND) vs Semaglutide (OZEMPIC®/WEGOVY®) switching from semaglutide to tirzepatide

How semaglutide affects less common blood markers Beyond the standard panels, semaglutide influences several markers that may appear on specialized or expanded blood work

Gradual Progression: Increase the intensity, duration, and frequency of exercise over time to avoid injury and improve fitness levels

and EU product information emphasise gastrointestinal adverse reactions (nausea, vomiting, diarrhoea, constipation, abdominal pain) as common with semaglutide, especially around dose escalation

Severe nausea from liraglutide (reported in 39.3% of patients at the 3.0 mg dose in the SCALE trial [6]) can cause prolonged fasting, dehydration, and electrolyte shifts

A randomised controlled trial with 961 participants compared the impact of a once-weekly dose of 1 mg or 2 mg of semaglutide on blood glucose levels and weight loss for people living with type 2 diabetes